Yield10 Bioscience Announces Closing of $3.7 Million Public Offering
15 Agosto 2023 - 12:00PM
Yield10 Bioscience, Inc. (Nasdaq:YTEN) (“Yield10” or the
“Company”), an agricultural bioscience company, today announced the
closing of its previously announced public offering of 5,750,000
units at a public offering price of $0.65 per unit. Each unit
consisted of one share of common stock and one warrant to purchase
one share of common stock. The warrants are immediately exercisable
at an exercise price of $0.65 per share and expire five years from
the date of issuance. The shares of common stock and accompanying
warrants could only be purchased together in this offering but were
issued separately and are immediately separable upon issuance.
Gross proceeds, before deducting placement agent
fees and other offering expenses, were approximately $3.7
million.
Maxim Group LLC and Lake Street Capital Markets,
LLC acted as joint placement agents for the offering.
The securities described above were offered
pursuant to a registration statement on Form S-1 (File No.
333-273240) that was filed with the U.S. Securities and Exchange
Commission (“SEC”) on July 14, 2023, as amended on August 2, 2023,
and declared effective on August 10, 2023. The offering was made
only by means of a prospectus which is part of the registration
statement. A final prospectus relating to and describing the terms
of the public offering was filed with the SEC. Copies
of the final prospectus relating to the offering may be obtained at
the SEC’s website www.sec.gov. Alternatively, copies of the final
prospectus may be obtained from Maxim Group LLC, 300 Park Avenue,
16th Floor, New York, New York 10022, Attention: Syndicate
Department, or via email at syndicate@maximgrp.com or telephone at
(212) 895-3745, or from Lake Street Capital Markets, LLC,
Attention: Syndicate Department, 920 Second Avenue South, Suite
700, Minneapolis, Minnesota 55402, or by emailing
syndicate@lakestreetcm.com or by calling (612) 326-1305.
This press release shall not constitute an offer
to sell or the solicitation of an offer to buy, nor shall there be
any sale of these securities in any state or jurisdiction in which
such offer, solicitation or sale would be unlawful prior to the
registration or qualification under the securities laws of any such
state or jurisdiction.
About Yield10
Bioscience
Yield10 Bioscience, Inc. is an agricultural
bioscience company that is using its differentiated trait gene
discovery platform, the “Trait Factory”, to develop improved
Camelina varieties for the production of proprietary seed products,
and to discover high value genetic traits for the agriculture and
food industries. Our goals are to efficiently establish a high
value seed products business based on developing superior varieties
of Camelina for the production of feedstock oils, PHA bioplastics
and omega-3 (EPA, DHA+EPA) oils, and to license our yield traits to
major seed companies for commercialization in major row crops,
including corn, soybean and canola. Yield10 is headquartered in
Woburn, MA and has a Canadian subsidiary, Yield10 Oilseeds Inc.,
located in Saskatoon, Canada.
(YTEN-G)
Safe Harbor for
Forward-Looking Statements
This press release contains forward-looking
statements which are made pursuant to the safe harbor provisions of
Section 27A of the Securities Act of 1933, as amended, and Section
21E of the Securities Exchange Act of 1934, as amended. The
forward-looking statements in this release do not constitute
guarantees of future performance. Investors are cautioned that
statements in this press release which are not strictly historical
constitute forward-looking statements. Such forward-looking
statements are subject to a number of risks and uncertainties that
could cause actual results to differ materially from those
anticipated, including the risks and uncertainties detailed in
Yield10's filings with the SEC. Yield10 assumes no obligation to
update any forward-looking information contained in this press
release or with respect to the matters described herein.
Contacts: Yield10
Bioscience:Lynne H. Brum, (617) 682-4693, LBrum@yield10bio.com
Investor Relations: Bret Shapiro, (561)
479-8566, brets@coreir.comManaging Director, CORE IR
Media Inquiries: Eric Fischgrund,
eric@fischtankpr.com FischTank PR
Yield10 Bioscience (NASDAQ:YTEN)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
Yield10 Bioscience (NASDAQ:YTEN)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024